Thrivent Financial for Lutherans’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7M Sell
101,992
-51,729
-34% -$2.94M 0.01% 834
2026
Q1
$9.87M Buy
153,721
+151,011
+5,572% +$13.8M 0.02% 637
2025
Q4
$347K Sell
2,710
-290
-10% -$39.8K ﹤0.01% 2370
2025
Q3
$323K Buy
3,000
+66
+2% +$7.19K ﹤0.01% 2214
2025
Q2
$267K Buy
+2,934
New +$230K ﹤0.01% 2332

Other funds holding WGS

Thrivent Financial for Lutherans's WGS Position: Q2 2026 in Review

Thrivent Financial for Lutherans reduced its GeneDx Holdings (WGS) stake by 34% in Q2 2026, selling an estimated $2.94M and leaving 101,992 shares worth $7M. The position accounts for 0.01% of the portfolio, ranked #834.

Thrivent Financial for Lutherans first reported a position in WGS in Q2 2025 and has held it in 5 quarters since. The position peaked at $9.87M in Q1 2026. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Thrivent Financial for Lutherans held 101,992 shares of GeneDx Holdings worth $7M as of Q2 2026.
  • Thrivent Financial for Lutherans sold 51,729 GeneDx Holdings shares in Q2 2026, an estimated $2.94M.
  • GeneDx Holdings made up 0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #834 holding.
  • Thrivent Financial for Lutherans first reported a position in GeneDx Holdings in Q2 2025 and has held it in 5 quarters since.
  • Thrivent Financial for Lutherans's GeneDx Holdings position peaked at $9.87M in Q1 2026.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.